person

Johan N.

Country
Sweden
Department
CTC Clinical Trial Consultants AB

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
1
Sites with multiple studies

Has run more than one trial at 1 of 25 partner sites.

Specializations

Metabolic and Endocrine Disorders

The investigator specializes in the treatment of diabetic complications and metabolic disorders, with particular focus on diabetic retinopathy and Type 2 diabetes. Their research extends to patients with elevated plasma triglycerides and metabolic dysfunction.

  • Diabetic eye disease management
  • Triglyceride regulation
  • Diabetes therapeutics

Inflammatory and Respiratory Conditions

The investigator conducts research in respiratory disorders, specifically focusing on idiopathic pulmonary fibrosis and complement-mediated diseases. Their work includes innovative approaches to treating inflammatory conditions.

  • Pulmonary fibrosis therapy
  • Complement system disorders
  • Inflammatory disease management

Cardiovascular and Musculoskeletal Health

The investigator's expertise encompasses cardiovascular disease and musculoskeletal conditions, with specialized focus on knee osteoarthritis. Their research includes innovative therapeutic approaches for joint disorders and cardiovascular health management.

  • Osteoarthritis treatment
  • Cardiovascular therapeutics
  • Joint disease management

Infectious Disease Prevention

The investigator conducts research in preventing pneumococcal disease, with particular emphasis on developing protective strategies for at-risk populations including children and adolescents.

  • Vaccine development
  • Immunological response studies
  • Pediatric infectious disease prevention

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.